Nektar Therapeutics (NKTR)
84.76
+0.77
(+0.92%)
USD |
NASDAQ |
Apr 17, 16:00
84.76
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Shareholders Equity (Quarterly) : 89.83M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 24.23B |
| Soleno Therapeutics, Inc. | 450.12M |
| Eli Lilly & Co. | 26.54B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Esperion Therapeutics, Inc. | -301.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 280.41M |
| Total Liabilities (Quarterly) | 190.57M |
| Debt to Equity Ratio | 1.658 |
| Current Ratio | 4.974 |
| Net Debt Paydown Yield | 1.56% |